January 07, 2024
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
January 05, 2024
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
January 04, 2024
NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference
November 19, 2023
NanoString Comments on Delaware District Court Verdict
November 09, 2023
NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience
November 09, 2023
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
November 06, 2023
NanoString Technologies Releases Operating Results for Third Quarter of 2023
November 01, 2023
NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available
October 10, 2023
NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023
October 03, 2023
A*STAR’s Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics
September 19, 2023
NanoString Comments on Unified Patent Court Order
September 14, 2023
NanoString to Host Virtual Spatial Genomics Summit September 19
September 13, 2023
NanoString Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered
September 07, 2023
NanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma Researchers
September 05, 2023
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
August 28, 2023
NanoString Appoints Todd Garland as Chief Commercial Officer
August 21, 2023
NanoString Platforms Advance Groundbreaking Studies of Immune Response in Pig-to-Human Organ Transplants
August 08, 2023
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
August 03, 2023
NanoString Technologies Releases Operating Results for Second Quarter of 2023
July 11, 2023
Delaware District Court Permits NanoString’s Counterclaims that 10x Genomics and Harvard Violated the Antitrust Laws
July 10, 2023
NanoString Provides Preliminary Financial and Operational Highlights for Second Quarter of 2023
June 30, 2023
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
June 09, 2023
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
June 08, 2023
Acrobat Genomics, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine to Discover New Drug Targets for Gene Editing-Based Therapeutics
June 01, 2023
Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells
May 31, 2023
NanoString to Webcast Presentation from Jefferies Healthcare Conference
May 22, 2023
NanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich
May 17, 2023
NanoString Responds to Decision of the Regional Court of Munich
May 03, 2023
NanoString Technologies Releases Operating Results for First Quarter of 2023
April 10, 2023
NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023
March 08, 2023
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
March 01, 2023
NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
February 28, 2023
NanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook
February 23, 2023
NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference
February 14, 2023
NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
February 06, 2023
NanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)
February 02, 2023
Weill Cornell Medicine and NanoString Collaborate to Create Comprehensive Spatial Atlas of Human Anatomy
January 19, 2023
NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager
January 08, 2023
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022
January 03, 2023
National Geographic Highlights Use of the CosMx Spatial Molecular Imager in Alzheimer’s Disease Research
December 22, 2022
NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 13, 2022
NanoString’s CosMx Spatial Molecular Imager Recognized by The Scientist Magazine as a Top 10 Innovation of 2022
December 06, 2022
NanoString Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform
November 10, 2022
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences
November 09, 2022
NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research
November 07, 2022
NanoString Technologies Releases Operating Results for Third Quarter of 2022
October 12, 2022
Spatial Imaging of 1,000 RNAs and 100 Proteins Using the CosMx Spatial Molecular Imager Published in Nature Biotechnology
October 12, 2022
NanoString to Release Third Quarter 2022 Operating Results and Host Conference Call on Monday, November 7, 2022
September 07, 2022
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
August 09, 2022
Study Using NanoString’s GeoMx Digital Spatial Profiler Featured on the Cover of Nature Genetics
Register for free today and gain instant access to over 15,000 stock hubs.